Bicarbonate

Bicarbonate

SCHEMBL5247907

O=C(O)O.OCC(O)c1cccs1

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.49
CES1 P23141 2/20 0.49
KEAP1 Q14145 1/20 0.49
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
KMT2A Q03164 2/20 0.43
CYP2C19 P33261 1/20 0.43
SLC5A2 P31639 1/20 0.41
ALOX5 P09917 1/20 0.41
DAO P14920 1/20 0.41
HTR1A P08908 2/20 0.40
GLS O94925 1/20 0.39
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
TSHR P16473 1/20 0.38
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ERCC5 P28715 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2251571 0.92
SCHEMBL5245778 0.92
SCHEMBL5246407 0.92
SCHEMBL4446826 0.81 CES2 (0.49) CES2CES1KEAP1NPC1RAB9A
SCHEMBL3962690 0.81 CES2 (0.49) CES2CES1KEAP1NPC1RAB9A
SCHEMBL28316937 0.81 CES2 (0.49) CES2CES1KEAP1NPC1RAB9A
Ethane SCHEMBL4831611 0.78 CES2 (0.46) CES2CES1KEAP1NPC1RAB9A
SCHEMBL6499256 0.78 NPC1 (0.48) CES2CES1KEAP1NPC1RAB9A
SCHEMBL4440609 0.77 NPC1 (0.57) CES2CES1KEAP1NPC1RAB9A
SCHEMBL28202930 0.77 DAO (0.43) CES2CES1KEAP1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1406605-B1 CARBAMATES OF 2-HETEROCYCLIC-1,2-ETHANEDIOLS SK CORP (KR) 2007-09-19 EP disclosed
US-20050065193-A1 Carbamates of 2-heterocyclic-1,2-ethanediols SK CORPORATION 2005-03-24 US disclosed
US-6841569-B2 Carbamates of 2-heterocyclic-1,2-ethanediols SK CORPORATION (US) 2005-01-11 US disclosed
US-20030078235-A1 Carbamates of 2-heterocyclic-1,2-ethanediols SK BIOPHARMACEUTICALS CO., LTD. (KR) 2003-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065193-A1 Carbamates of 2-heterocyclic-1,2-ethanediols CNR2, CNR1, GRIN2C CES2 8/4885CES1 159/4885KEAP1 2923/4885
US-20030078235-A1 Carbamates of 2-heterocyclic-1,2-ethanediols CNR2, CNR1, GRIN2C CES2 8/4885CES1 159/4885KEAP1 2923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.